Gateway Biotechnology, Inc.赞助的临床试验
总计268个结果
-
Washington University School of MedicineUnited States Department of Defense; University of Texas; Gateway Biotechnology, Inc.终止
-
AVM Biotechnology IncMedpace, Inc.尚未招聘新冠肺炎 | 流感,人类 | ARDS
-
GlaxoSmithKlineVir Biotechnology, Inc.终止
-
Vir Biotechnology, Inc.GlaxoSmithKline完全的
-
Vir Biotechnology, Inc.GlaxoSmithKline招聘中
-
Vir Biotechnology, Inc.GlaxoSmithKline终止
-
Vir Biotechnology, Inc.GlaxoSmithKline完全的
-
Vir Biotechnology, Inc.GlaxoSmithKline完全的
-
NSABP Foundation IncPuma Biotechnology, Inc.完全的
-
NSABP Foundation IncPuma Biotechnology, Inc.主动,不招人
-
NSABP Foundation IncPuma Biotechnology, Inc.完全的
-
Hebei Senlang Biotechnology Inc., Ltd.招聘中
-
Hebei Senlang Biotechnology Inc., Ltd.招聘中
-
Beijing Health Guard Biotechnology, Inc主动,不招人
-
Shanghai Longyao Biotechnology Inc., Ltd.未知
-
Hebei Senlang Biotechnology Inc., Ltd.招聘中
-
Hebei Senlang Biotechnology Inc., Ltd.招聘中
-
Vir Biotechnology, Inc.Alnylam Pharmaceuticals完全的
-
Hebei Senlang Biotechnology Inc., Ltd.招聘中
-
Vir Biotechnology, Inc.Alnylam Pharmaceuticals主动,不招人
-
Gilead SciencesVir Biotechnology, Inc.主动,不招人慢性乙型肝炎香港, 大韩民国, 丹麦, 澳大利亚, 泰国, 新加坡, 英国, 新西兰
-
Hebei Senlang Biotechnology Inc., Ltd.主动,不招人用于 CD7+ T 细胞淋巴母细胞白血病或 T 细胞淋巴母细胞淋巴瘤的 SenL-T7 CAR T 细胞中国
-
Hebei Senlang Biotechnology Inc., Ltd.完全的
-
Shanghai Longyao Biotechnology Inc., Ltd.未知
-
University of FloridaGateway for Cancer Research; Cellworks Group Inc.终止
-
M.D. Anderson Cancer CenterGateway for Cancer Research; Theravalues, Inc.完全的
-
Orthomedico Inc.BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED完全的